Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

11.37

+0.36 (3.27%)

At close: Apr 28, 2026, 4:00 PM EDT

11.37

0.00 (0.00%)

After-hours: Apr 28, 2026, 4:47 PM EDT

Keros Therapeutics Market Cap

Keros Therapeutics has a market cap or net worth of $224.99 million as of April 28, 2026. Its market cap has decreased by -54.68% in one year.

Market Cap

224.99M

Enterprise Value

-45.54M

1-Year Change

-54.68%

Ranking

#3826

Market Cap Chart

Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $224.99M, a decrease of -41.61%. That is a compound annual growth rate of -8.50%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	217.09M	-65.00%
Dec 31, 2025	620.29M	-3.27%
Dec 31, 2024	641.23M	-46.17%
Dec 29, 2023	1.19B	-9.94%
Dec 30, 2022	1.32B	-3.39%
Dec 31, 2021	1.37B	-16.27%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Codexis	238.08M
Fennec Pharmaceuticals	235.81M
Nuvectis Pharma	235.78M
Milestone Pharmaceuticals	231.81M
Camp4 Therapeutics	230.52M
Polaryx Therapeutics	229.61M
Voyager Therapeutics	225.88M
ALX Oncology Holdings	224.72M

Market Cap Rankings